Hyperbaric Oxygenation in Treatment of Alcohol Dependence Syndrome
NCT ID: NCT03470168
Last Updated: 2018-03-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2014-11-30
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hyperbaric Oxygen Therapy Compared to Cognitive Training in FASD
NCT04664790
Outpatient Treatment of Alcohol Withdrawal Syndrome
NCT00136617
Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal
NCT00936377
Oxytocin Treatment of Alcohol Dependence
NCT02275611
Inpatient Alcohol Detox & Psychotherapy
NCT03988478
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The total of 30 patients divided to A: Treatment group and B: Control using Simple randomization technique using random number generating software (ver. 1). A, received the Hyperbaric Oxygen therapy treatment at 2.4 ATA for 90 minutes each day. B were also taken inside the Hyperbaric Chamber, but received only normobaric oxygen therapy for the same period of time at 1 ATA. All of the cases received all standard medications. Hyperbaric oxygenation was done at our hospital in a monoplace chamber (Oxicab,HyperbaricSAC, Peru). The entire session was carried out in presence of the Hyperbaric Physician and technician. Prior to this therapy the documentation of pulse rate, Blood Pressure and Blood sugar were done as standard procedure. The Hyperbaric sessions were done for 10 days in a row one time daily. Daily general examination, systemic examination, detailed mental status examination and administration of CIWA scale and DOS scale were carried out till the day of discharge.
Laboratory investigations were repeated after two weeks. The patients were discharged when the biological functions were adequate, physical and mental conditions were stable and when they were motivated to remain abstinent from alcohol. Parameters assessed in two groups were compared.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hyperbaric Oxygen Therapy
Received the Hyperbaric Oxygen therapy treatment at 2.4 ATA for 90 minutes each day.
Hyperbaric Oxygenation Therapy
Received the Hyperbaric Oxygen therapy treatment at 2.4 ATA for 90 minutes each day.
Placebo group
were also taken inside the Hyperbaric Chamber, but received only normobaric oxygen therapy for the same period of time at 1 ATA
Normobaric Oxygenation therapy
Received the Normobaric Oxygen therapy treatment at 1 ATA for 90 minutes each day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hyperbaric Oxygenation Therapy
Received the Hyperbaric Oxygen therapy treatment at 2.4 ATA for 90 minutes each day.
Normobaric Oxygenation therapy
Received the Normobaric Oxygen therapy treatment at 1 ATA for 90 minutes each day.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
60 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
INCRE fellowship from DBT, govt of India
UNKNOWN
Jubilee Mission Medical College and Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Geomy George Chakkalakkudy
Assistant Professor, Department of Psychiatry
References
Explore related publications, articles, or registry entries linked to this study.
Sassi,F.(ed.), Tackling Harmful Alcohol Use: Economics and Public Health Policy, OECD Publishing, Paris 2015.
World Health Organization (WHO) -Global Status report on Alcohol and Health -2014
American psychiatric association; Diagnostic and statistical manual of mental disorders; 4th edition; Text Revision (DSM IV TR)
Caetano R, Clark CL, Greenfield TK. Prevalence, trends, and incidence of alcohol withdrawal symptoms: analysis of general population and clinical samples. Alcohol Health Res World. 1998;22(1):73-9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
25/16/IEC/JMMC&RI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.